Osicent 80 mg (Osimertinib) is a targeted therapy for EGFR-mutated non-small cell lung cancer (NSCLC). It blocks cancer cell growth and spread. Common side effects include diarrhea, rash, dry skin, and nail changes. It should be taken under strict medical supervision. https://oncologymedi.com/product/osicent-80-mg-osimertinib/